These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Should patients with Barrett's oesophagus be kept under surveillance? The case for. Armstrong D Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of Barrett's oesophagus. A general survey. Petrakis IE; Sciacca V; Iascone C Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051 [TBL] [Abstract][Full Text] [Related]
8. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus. Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565 [TBL] [Abstract][Full Text] [Related]
10. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study. Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591 [TBL] [Abstract][Full Text] [Related]
11. Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study. Timmer MR; Martinez P; Lau CT; Westra WM; Calpe S; Rygiel AM; Rosmolen WD; Meijer SL; Ten Kate FJ; Dijkgraaf MG; Mallant-Hent RC; Naber AH; van Oijen AH; Baak LC; Scholten P; Böhmer CJ; Fockens P; Maley CC; Graham TA; Bergman JJ; Krishnadath KK Gut; 2016 Oct; 65(10):1602-10. PubMed ID: 26104750 [TBL] [Abstract][Full Text] [Related]
12. [Revision needed of follow-up policy for Barrett's esophagus]. Giard RW; Coebergh JW; Ouwendijk RJ Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562 [TBL] [Abstract][Full Text] [Related]
13. Barrett's oesophagus: epidemiology, cancer risk and implications for management. de Jonge PJ; van Blankenstein M; Grady WM; Kuipers EJ Gut; 2014 Jan; 63(1):191-202. PubMed ID: 24092861 [TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study. Moghissi K; Sharpe DA; Pender D Eur J Cardiothorac Surg; 1993; 7(3):126-31. PubMed ID: 8461144 [TBL] [Abstract][Full Text] [Related]
15. Management of Barrett's esophagus. Cameron AJ Mayo Clin Proc; 1998 May; 73(5):457-61. PubMed ID: 9581588 [TBL] [Abstract][Full Text] [Related]
16. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus. Jankowski JA; Anderson M Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468 [TBL] [Abstract][Full Text] [Related]
17. [Surveillance for Barrett's oesophagus: worthwhile?]. Kastelein F; Kuipers EJ Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039 [TBL] [Abstract][Full Text] [Related]
18. Should patients with Barrett's oesophagus be kept under surveillance? The case against. Barritt AS; Shaheen NJ Best Pract Res Clin Gastroenterol; 2008; 22(4):741-50. PubMed ID: 18656827 [TBL] [Abstract][Full Text] [Related]
19. A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance. Gudlaugsdottir S; van Blankenstein M; Dees J; Wilson JH Eur J Gastroenterol Hepatol; 2001 Jun; 13(6):639-45. PubMed ID: 11434588 [TBL] [Abstract][Full Text] [Related]
20. Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer? Mayne GC; Bright T; Hussey DJ; Watson DI ANZ J Surg; 2012 Sep; 82(9):592-8. PubMed ID: 22901306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]